Subtopic Deep Dive

Antibiotic Resistance in Acne Therapy
Research Guide

What is Antibiotic Resistance in Acne Therapy?

Antibiotic resistance in acne therapy refers to the evolution of resistance in Cutibacterium acnes to macrolides and tetracyclines used in acne vulgaris treatment.

Resistance in C. acnes to topical and oral antibiotics has increased globally, complicating acne management (Dréno et al., 2018; 521 citations). Studies highlight the role of skin microbiome dysbiosis in treatment failures (Platsidaki and Dessinioti, 2018; 193 citations). Clinical guidelines recommend limiting antibiotic monotherapy and combining with benzoyl peroxide or retinoids (Reynolds et al., 2024; 302 citations).

10
Curated Papers
3
Key Challenges

Why It Matters

Rising C. acnes resistance leads to higher acne treatment failures and increased healthcare costs, with global prevalence exceeding 50% in some regions (Dréno et al., 2018). Stewardship strategies preserve antibiotic efficacy; Reynolds et al. (2024) guidelines reduce resistance by favoring non-antibiotic topicals like retinoids and benzoyl peroxide. O’Neill and Gallo (2018) link microbiome shifts to persistent inflammation, informing microbiome-targeted therapies. Platsidaki and Dessinioti (2018) emphasize combination regimens to combat resistance evolution.

Key Research Challenges

Tracking Resistance Evolution

Monitoring C. acnes phylotypes and resistance genes over time is challenging due to strain diversity (Dréno et al., 2018). Longitudinal studies show macrolide resistance rising to 40-80% in Europe (Platsidaki and Dessinioti, 2018). Clinical correlation with treatment outcomes remains inconsistent.

Developing Stewardship Strategies

Balancing antibiotic use with alternatives like retinoids is difficult amid guideline adherence issues (Reynolds et al., 2024). Dréno et al. (2020) note poor compliance increases resistance selection. Trials for fixed-dose combinations are limited.

Assessing Microbiome Impact

Distinguishing resistance-driven dysbiosis from other acne factors requires advanced sequencing (O’Neill and Gallo, 2018). Lee et al. (2019) highlight gaps in causal microbiome links to inflammation. Interventions targeting microbiome restoration lack long-term data.

Essential Papers

1.

<i>Cutibacterium acnes</i> (<i>Propionibacterium acnes</i>) and acne vulgaris: a brief look at the latest updates

Brigitte Dréno, S. Pécastaings, Stéphane Corvec et al. · 2018 · Journal of the European Academy of Dermatology and Venereology · 521 citations

Abstract While the commensal bacterium Propionibacterium acnes ( P. acnes ) is involved in the maintenance of a healthy skin, it can also act as an opportunistic pathogen in acne vulgaris. The late...

2.

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions

Britta De Pessemier, Lynda Grine, Melanie Debaere et al. · 2021 · Microorganisms · 519 citations

The microbiome plays an important role in a wide variety of skin disorders. Not only is the skin microbiome altered, but also surprisingly many skin diseases are accompanied by an altered gut micro...

3.

Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris

Alan M. O’Neill, Richard L. Gallo · 2018 · Microbiome · 304 citations

Acne is one of the most common skin diseases worldwide and results in major health care costs and significant morbidity to severely affected individuals. However, the pathophysiology of this disord...

4.

Guidelines of care for the management of acne vulgaris

Rachel V. Reynolds, Howa Yeung, Carol E. Cheng et al. · 2024 · Journal of the American Academy of Dermatology · 302 citations

5.

Potential Role of the Microbiome in Acne: A Comprehensive Review

Young Bok Lee, Eun Jung Byun, Hei Sung Kim · 2019 · Journal of Clinical Medicine · 284 citations

Acne is a highly prevalent inflammatory skin condition involving sebaceous sties. Although it clearly develops from an interplay of multiple factors, the exact cause of acne remains elusive. It is ...

6.

The Skin Microbiome: A New Actor in Inflammatory Acne

Brigitte Dréno, Marie Ange Dagnelie, Amir Khammari et al. · 2020 · American Journal of Clinical Dermatology · 283 citations

7.

Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne

Eftychia Platsidaki, Clio Dessinioti · 2018 · F1000Research · 193 citations

<ns4:p>The skin commensal <ns4:italic>Propionibacterium acnes</ns4:italic>, recently renamed <ns4:italic>Cutibacterium acnes</ns4:italic>, along with the other major pathophysiological factors of i...

Reading Guide

Foundational Papers

No pre-2015 foundational papers available; start with Dréno et al. (2018; 521 citations) for comprehensive C. acnes updates establishing resistance context.

Recent Advances

Reynolds et al. (2024; 302 citations) for latest guidelines; Dréno et al. (2020; 283 citations) on skin microbiome in inflammatory acne; O’Neill and Gallo (2018; 304 citations) for host interactions.

Core Methods

MLST phylotyping, resistance gene PCR (erm, tetM), 16S rRNA sequencing, MIC determination via CLSI standards (Dréno et al., 2018; Platsidaki and Dessinioti, 2018).

How PapersFlow Helps You Research Antibiotic Resistance in Acne Therapy

Discover & Search

Research Agent uses searchPapers and exaSearch to find 50+ papers on C. acnes resistance, then citationGraph on Dréno et al. (2018; 521 citations) reveals connected works like Platsidaki and Dessinioti (2018). findSimilarPapers expands to global resistance patterns.

Analyze & Verify

Analysis Agent applies readPaperContent to extract resistance rates from Reynolds et al. (2024), verifies claims with CoVe against O’Neill and Gallo (2018), and runs PythonAnalysis on prevalence data for statistical trends using pandas. GRADE grading scores guideline evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in stewardship trials via gap detection, flags contradictions between Dréno et al. (2018) and Lee et al. (2019). Writing Agent uses latexEditText, latexSyncCitations for guideline summaries, and latexCompile for publication-ready reviews with exportMermaid for resistance phylotype diagrams.

Use Cases

"Analyze resistance rates in C. acnes from 10 recent acne papers using statistics."

Research Agent → searchPapers → Analysis Agent → readPaperContent on Dréno et al. (2018) → runPythonAnalysis (pandas aggregation of rates across studies) → matplotlib trend plot output.

"Draft LaTeX review on acne antibiotic stewardship guidelines."

Synthesis Agent → gap detection → Writing Agent → latexEditText for intro → latexSyncCitations (Reynolds et al., 2024) → latexCompile → PDF with resistance flowchart.

"Find code for C. acnes microbiome analysis from acne papers."

Research Agent → searchPapers (microbiome acne) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → validated NGS pipeline for resistance gene detection.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ papers on C. acnes resistance: searchPapers → citationGraph → GRADE all → structured report with prevalence meta-analysis. DeepScan applies 7-step analysis to Dréno et al. (2018) with CoVe checkpoints for resistance claims. Theorizer generates hypotheses on microbiome interventions from O’Neill and Gallo (2018) patterns.

Frequently Asked Questions

What defines antibiotic resistance in acne therapy?

It is the reduced susceptibility of Cutibacterium acnes to macrolides and tetracyclines, driven by clonal expansion of resistant phylotypes (Dréno et al., 2018).

What methods track C. acnes resistance?

PCR for erm and tet genes, MLST for phylotyping, and 16S sequencing assess resistance; culture-based MIC testing confirms clinical relevance (Platsidaki and Dessinioti, 2018).

What are key papers on this topic?

Dréno et al. (2018; 521 citations) updates C. acnes role; Reynolds et al. (2024; 302 citations) provides management guidelines; O’Neill and Gallo (2018; 304 citations) details host-microbiome interactions.

What open problems exist?

Long-term efficacy of non-antibiotic combinations, global resistance surveillance standardization, and microbiome restoration therapies lack robust trials (Dréno et al., 2020).

Research Acne and Rosacea Treatments and Effects with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Antibiotic Resistance in Acne Therapy with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers